NCT05691478 2026-03-19
A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
National Cancer Institute (NCI)
Phase 2/3 Recruiting
National Cancer Institute (NCI)
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center